The UHC stock forecast suggests valuation remains fair, trading at roughly 22x forward earnings compared to industry averages near 18x, reflecting premium quality and predictable margins. "Management noted care activity trends continue to run ahead of its previous expectations driven by a greater than expected impact at UHC from new members, further acceleration of [Medicare Advantage] utilization and indications of potential broadening trend among adjacent, complex populations," Truist Securities analysts wrote in a May analyst note about UnitedHealth. Lauricella : Coming into 2025, the stock had done very well for many years. What drove that strength? Options market data suggests bullish sentiment in the UHC stock forecast, with call volumes outpacing puts by nearly 1.5x over recent trading weeks.